Back
Rapid7, Inc. 10K Form
Sell
45
RPD
Rapid7, Inc.
Last Price:
$6.57
Seasonality Move:
-1.93%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-06 | 10Q | RPD/Rapid7, Inc. Quarterly |
| 2023-08-09 | 10Q | RPD/Rapid7, Inc. Quarterly |
| 2023-05-10 | 10Q | RPD/Rapid7, Inc. Quarterly |
| 2022-11-03 | 10Q | RPD/Rapid7, Inc. Quarterly |
| 2022-08-04 | 10Q | RPD/Rapid7, Inc. Quarterly |
| 2022-05-05 | 10Q | RPD/Rapid7, Inc. Quarterly |
Receive RPD News And Ratings
See the #1 stock for the next 7 days that we like better than RPD
RPD Financial Statistics
Sales & Book Value
| Annual Sales: | $859.8M |
|---|---|
| Cash Flow: | $32.3M |
| Price / Cash Flow: | 3.33 |
| Annual Sales: | $2.35 |
| Price / Book: | 2.78 |
Profitability
| EPS (TTM): | 0.35970 |
|---|---|
| Net Income (TTM): | $23.4M |
| Gross Margin: | $595.4M |
| Return on Equity: | 26.4% |
| Return on Assets: | 1.4% |
Rapid7, Inc. Earnings Forecast
Key Rapid7, Inc. Financial Ratios
-
The Gross Profit Margin over the past 14 years for RPD is 69.25%.
-
The Selling, General & Administrative Expenses for RPD have been equal to 46.82% of Gross Profit Margin.
-
The Research & Development expenses have been 21.86% of Revenue.
-
The Interest Expense is 44.63% of Operating Income.
-
The Net Earning history of RPD is 2.72% of Total Revenues.
-
Per Share Earnings over the last 14 years have been positive in 5 years.
Rapid7, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Software |
| Sector: | Information Technology |
| Current Symbol: | RPD |
| CUSIP: | 753422 |
| Website: | rapid7.com |
Debt
| Debt-to-Equity Ratio: | 6.26 |
|---|---|
| Current Ratio: | 1.2 |
| Quick Ratio: | 1.12 |
Price-to-Earnings
| Trailing P/E Ratio: | 18.27 |
|---|---|
| Forward P/E Ratio: | 4.08 |
RPD Technical Analysis vs Fundamental Analysis
Sell
45
Rapid7, Inc. (RPD)
is a Sell
Is Rapid7, Inc. a Buy or a Sell?
-
Rapid7, Inc. stock is rated a SellThe current Rapid7, Inc. [RPD] share price is $6.57. The Score for RPD is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.